TABLE 62-2.
Efficacy of PCV7 in Finnish Children with Acute Otitis Media (AOM)
| END POINT | AOM EPISODES |
VACCINE EFFICACY POINT ESTIMATE (%) | |
|---|---|---|---|
| PCV7 (N = 831) | Control* (N = 831) | ||
| Any AOM | 1251 | 1345 | 6 |
| Pneumococcal AOM | 271 | 414 | 34 |
| Vaccine serotypes | 107 | 250 | 57 |
| Cross-reactive serotypes | 41 | 84 | 51 |
| Nonvaccine serotypes | 125 | 95 | −33 |
| Haemophilus influenzae AOM | 315 | 287 | −11 |
| Moraxella catarrhalis AOM | 379 | 381 | −1 |
Hepatitis B vaccine.
Data from Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403-409.